Cesca Therapeutics teams up with Sloan Kettering on stem cell purification applications

Cesca Therapeutics (KOOL +0.4%) enters into a collaboration with Memorial Sloan Kettering’s Center for Immune Cell Therapies (CICT) under which it will use the company’s newest version of its AutoXpress platform in a CICT-initiated study within the …

[Read the full article here]

Comments are closed.